Abstract
Although investigators using methodologies in bioinformatics have always been useful in genomic experimentation in analytic, engineering, and infrastructure support roles, only recently have bioinformaticians been able to have a primary scientific role in asking and answering questions on human health and disease. Here, I argue that this shift in role towards asking questions in medicine is now the next step needed for the field of bioinformatics. I outline four reasons why bioinformaticians are newly enabled to drive the questions in primary medical discovery: public availability of data, intersection of data across experiments, commoditization of methods, and streamlined validation. I also list four recommendations for bioinformaticians wishing to get more involved in translational research.
Introduction
Historically, the field of bioinformatics has been viewed primarily as a service-oriented discipline. Bioinformaticians were the "engineers" of the genomic revolution—building databases, managing pipelines, and providing the computational tools necessary for bench scientists to interpret their results. However, as the volume of biomedical data reaches a critical mass, a fundamental shift is occurring. The bioinformatician is moving from a support role to that of a primary investigator, capable of generating and testing original hypotheses about human health.
The Four Pillars of the New Bioinformatics
The transition of bioinformatics into a primary discovery science is driven by four key "enabling opportunities" that have matured over the last decade.
1. Public Data Availability
The culture of biological research has shifted from siloed, private data to massive public repositories. Resources like the NCBI Gene Expression Omnibus (GEO) have grown exponentially; at the time of this framework's proposal, GEO contained over 300,000 microarrays from over 12,000 experiments. This "public laboratory" allows researchers to access high-quality data without the overhead of performing the initial wet-lab experiments.
2. Data Intersection and Meta-analysis
The true power of bioinformatics lies in the ability to synthesize information across hundreds of independent experiments. By intersecting disparate datasets—such as combining gene expression profiles with proteomics and clinical outcomes—researchers can identify "common denominators" in complex diseases like cancer or obesity that would be invisible in a single-study context.
3. Commoditization of Methodology
Sophisticated analytical methods are no longer the exclusive domain of algorithm developers. The rise of user-friendly, open-source tools (e.g., the Weka machine learning suite) and standardized web servers has lowered the barrier to entry. This allows researchers to focus less on the "how" of the computation and more on the "what" of the biological discovery.
4. Streamlined Validation
Perhaps the most significant change is the ability to validate computational findings without a traditional wet lab. Commercial services now provide access to human samples in standardized formats. For example, tissue microarrays (TMAs) allow a researcher to test a predicted biomarker across hundreds of patient samples simultaneously, effectively outsourcing the physical validation of "dry-lab" hypotheses.
Humans as the Ultimate Model Organism
A core tenet of translational bioinformatics is the prioritization of human data. While animal models are essential, the sheer scale and clinical relevance of human data—ranging from electronic health records (EHRs) to pathology images—often provide a more direct path to medical discovery. By treating humans as the primary model organism, bioinformaticians can address questions that are directly applicable to patient care.
Recommendations for the Translational Bioinformatician
To successfully navigate this shift, bioinformaticians should adopt a more clinical perspective:
- Focus on the Question: The hardest part of science is asking the right question. Bioinformaticians must take ownership of the scientific inquiry rather than waiting for a collaborator to provide the hypothesis.
- Attend Medical Grand Rounds: To understand the real-world challenges of medicine, researchers should leave the server room and engage with clinicians and patients to see where the data meets the bedside.
- Specialize in a Domain: Depth of knowledge in a specific medical sub-field is crucial for interpreting data accurately and identifying meaningful patterns.
- Embrace "Messy" Data: While metadata standards like MIAME are important, researchers should not wait for perfect data before beginning analysis. The value lies in finding truth within the existing, albeit imperfect, public record.
Conclusion
The evolution of bioinformatics from a service role to a primary scientific role is not just an opportunity; it is a necessity for the advancement of genome medicine. By leveraging public data and streamlined validation techniques, bioinformaticians are uniquely positioned to lead the way toward "P4 medicine": proactive, predictive, preventative, and participatory health.
Summary updated